ABBV vs. AZN: A Head-to-Head Stock Comparison

Company Overview

With ABBV at 321.13 billion USD and AZN at 432.07 billion USD, their market capitalizations sit in the same ballpark.

ABBV’s beta of 0.55 points to much larger expected swings compared to AZN’s calmer 0.18, suggesting both higher upside and downside potential.

AZN is an ADR, letting U.S. buyers tap its non-U.S. business directly, unlike ABBV, which is purely domestic.

Performance Comparison

This chart compares the performance of ABBV and AZN over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).

Hover over the lines to see the investment’s value and total return (%) at specific dates.

Data is adjusted for dividends and splits.

Valuation Metrics Comparison

For a detailed comparison of valuation metrics between ABBV and AZN, please refer to the table below.

Dividend Comparison

ABBV’s dividend yield of 3.51% is about 153% higher than AZN’s 1.39%, underscoring its stronger focus on returning cash to shareholders.

Financial Strength Metrics Comparison

This section dives into the financial resilience of ABBV and AZN, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.

• With current ratios of 0.76 and 0.90, both ABBV and AZN have less current assets than short-term liabilities, which could strain their working capital and force reliance on additional financing.
• Both ABBV (quick ratio 0.64) and AZN (quick ratio 0.70) fall below 0.8, meaning their most liquid assets—excluding inventory—aren’t enough to meet short-term obligations. This could force them to rely on receivables, inventory turn, or external financing.
• ABBV is heavily leveraged (debt-to-equity ratio 49.22), which can boost returns but raises risk if borrowing costs climb, while AZN at 0.77 keeps leverage at a more moderate level.